###################################################################################################################################################################
#Enrichment results using 'Biological Process from Gene Ontology (GO)', created by dcGO Enrichment at 12/08/2016 12:58:36 (day/month/year hour:min:sec)
#Citation: Fang H, Gough J. (2012) dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res (PubMed ID: 23161684)
###################################################################################################################################################################
#
#'GroupID' column: group id (by default 'Group' for single group);
#'GO ID' column: the identifier of ontological terms;
#'GO term' column: the name of ontological terms;
#'xxxx (four levels)' column: term specificity (only appear when using slim version of the ontology; 1 for highly general, 2 for general, 3 for specific, and 4 for highly specific);
#'Z-score' column: Z-score being calculated based on hypergeometric distribution;
#'P-value' column: P-value being calculated based on hypergeometric distribution;
#'FDR' column: FDR used to assess the statistical significance of term enrichments;
#'#Domains (Overlaps|Group|Term|Background)' column: the number of domains, i.e., 'Overlaps' for the number of domains in the input group but also being annotated by the term; 'Group' for the number of domains in the input group (also annotatable by the ontology); 'Term' for the number of domains being annotated by the term; 'Backgroud' for the number of domains that are annotatable by the ontology.
#'Annotated domains' column: a list of semicolon-separated domains in the input group but also being annotated by the term.
#
GroupID	GO ID	GO term	PFAM slim (four levels)	Z-score	P-value	FDR	#Domains (Overlaps|Group|Term|Background)	Annotated domains
Group	GO:0023051	regulation of signaling	1	10.49	3.22e-19	2.11e-16	71|193|441|3527	PF00019;PF00027;PF00040;PF00057;PF00093;PF00122;PF00130;PF00169;PF00179;PF00240;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF01030;PF01064;PF01403;PF01417;PF01437;PF01585;PF01699;PF01753;PF01833;PF01843;PF02145;PF02148;PF02177;PF02214;PF02218;PF02377;PF02825;PF03165;PF03226;PF04055;PF06920;PF07525;PF07645;PF07653;PF07679;PF09324;PF10409;PF12763;PF12783;PF12796;PF12924;PF13716;PF13855;PF13920;PF14324;PF14429
Group	GO:0006928	cellular component movement	1	10.63	3.41e-18	7.36e-16	56|193|296|3527	PF00019;PF00024;PF00045;PF00052;PF00053;PF00055;PF00057;PF00130;PF00169;PF00226;PF00241;PF00341;PF00388;PF00397;PF00400;PF00413;PF00435;PF00594;PF00611;PF00612;PF00618;PF00640;PF00684;PF00688;PF00757;PF00778;PF00786;PF00989;PF01030;PF01064;PF01217;PF01403;PF01437;PF01833;PF01843;PF02148;PF02177;PF02181;PF02185;PF02214;PF03133;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07719;PF10409;PF12348;PF12473;PF12924;PF13855;PF14429
Group	GO:0032879	regulation of localization	1	10.49	4.51e-18	7.36e-16	58|193|318|3527	PF00019;PF00027;PF00040;PF00045;PF00055;PF00076;PF00093;PF00098;PF00122;PF00130;PF00169;PF00254;PF00341;PF00388;PF00397;PF00400;PF00413;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00969;PF01030;PF01064;PF01217;PF01403;PF01437;PF01833;PF01843;PF02145;PF02185;PF02214;PF04055;PF04144;PF04810;PF07645;PF07653;PF07679;PF08246;PF10409;PF12697;PF12796;PF13091;PF13716;PF13855;PF13903;PF13920
Group	GO:0048519	negative regulation of biological process	1	9.70	2.26e-18	7.36e-16	89|193|681|3527	PF00019;PF00024;PF00057;PF00076;PF00093;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00241;PF00254;PF00341;PF00350;PF00388;PF00389;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00611;PF00622;PF00640;PF00643;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00789;PF00969;PF01030;PF01064;PF01335;PF01403;PF01417;PF01477;PF01585;PF01699;PF01753;PF01833;PF01909;PF02145;PF02148;PF02177;PF02181;PF02201;PF02214;PF02709;PF02826;PF03165;PF03226;PF04055;PF05033;PF05773;PF06297;PF07525;PF07645;PF07653;PF07679;PF07719;PF08210;PF08246;PF10277;PF10409;PF10421;PF12348;PF12697;PF12763;PF12796;PF12906;PF12924;PF13716;PF13733;PF13854;PF13855;PF13920;PF14324
Group	GO:0048518	positive regulation of biological process	1	9.55	8.38e-18	1.09e-15	87|193|667|3527	PF00019;PF00024;PF00025;PF00027;PF00040;PF00053;PF00055;PF00057;PF00076;PF00093;PF00098;PF00122;PF00130;PF00133;PF00134;PF00169;PF00179;PF00240;PF00241;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00594;PF00611;PF00612;PF00618;PF00640;PF00643;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF00989;PF01030;PF01064;PF01335;PF01403;PF01417;PF01437;PF01476;PF01585;PF01699;PF01833;PF02177;PF02181;PF02185;PF02218;PF02825;PF02845;PF03165;PF04055;PF04144;PF05790;PF06367;PF06371;PF07525;PF07534;PF07645;PF07653;PF07679;PF07719;PF08210;PF08246;PF09816;PF10409;PF11717;PF12171;PF12697;PF12756;PF12763;PF12796;PF12924;PF13091;PF13716;PF13855;PF13920;PF14324
Group	GO:0048583	regulation of response to stimulus	1	9.20	6.70e-16	7.29e-14	71|193|503|3527	PF00019;PF00027;PF00040;PF00057;PF00093;PF00122;PF00130;PF00169;PF00179;PF00240;PF00341;PF00388;PF00397;PF00400;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF01030;PF01064;PF01217;PF01403;PF01417;PF01437;PF01476;PF01585;PF01753;PF01833;PF01843;PF02145;PF02148;PF02177;PF02214;PF02218;PF02377;PF02825;PF03165;PF03226;PF04055;PF06920;PF07525;PF07534;PF07645;PF07653;PF07679;PF08246;PF10409;PF12763;PF12796;PF12924;PF13716;PF13855;PF13920;PF14324;PF14429
Group	GO:0051128	regulation of cellular component organization	1	9.56	9.99e-16	9.32e-14	56|193|333|3527	PF00019;PF00024;PF00025;PF00130;PF00134;PF00169;PF00179;PF00226;PF00241;PF00254;PF00341;PF00397;PF00400;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00688;PF00757;PF00780;PF00786;PF01030;PF01064;PF01403;PF01437;PF01833;PF01843;PF02145;PF02148;PF02181;PF02185;PF03165;PF06367;PF06371;PF07645;PF07653;PF07679;PF07707;PF07719;PF08210;PF10409;PF12348;PF12796;PF12895;PF12906;PF13091;PF13855;PF13920
Group	GO:0010646	regulation of cell communication	1	9.48	1.52e-15	1.10e-13	56|193|336|3527	PF00019;PF00027;PF00040;PF00057;PF00093;PF00122;PF00130;PF00169;PF00179;PF00240;PF00341;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00618;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF01030;PF01064;PF01403;PF01417;PF01437;PF01585;PF01699;PF01833;PF02145;PF02214;PF02218;PF02825;PF03165;PF03226;PF04055;PF07525;PF07645;PF07653;PF07679;PF10409;PF12763;PF12796;PF13716;PF13855;PF13920;PF14324
Group	GO:0030030	cell projection organization	1	9.46	1.18e-14	6.99e-13	46|193|246|3527	PF00019;PF00024;PF00025;PF00052;PF00053;PF00055;PF00130;PF00169;PF00341;PF00397;PF00400;PF00415;PF00435;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00640;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01437;PF01833;PF02148;PF02177;PF02377;PF03133;PF03165;PF03607;PF07645;PF07653;PF07679;PF07719;PF12348;PF12796;PF12924;PF13716;PF13855
Group	GO:0065009	regulation of molecular function	1	8.99	1.11e-14	6.99e-13	60|193|396|3527	PF00019;PF00025;PF00027;PF00057;PF00076;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00254;PF00341;PF00388;PF00397;PF00400;PF00415;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00688;PF00757;PF00778;PF00780;PF00786;PF00899;PF01335;PF01403;PF01437;PF01585;PF01909;PF02145;PF02148;PF02177;PF02377;PF03165;PF04055;PF06920;PF07525;PF07645;PF07653;PF07679;PF08246;PF09324;PF10421;PF12796;PF12924;PF13716;PF13855;PF13903;PF13920;PF14429
Group	GO:0051674	localization of cell	1	9.45	1.80e-14	9.82e-13	44|193|229|3527	PF00019;PF00024;PF00045;PF00052;PF00053;PF00055;PF00057;PF00130;PF00226;PF00241;PF00341;PF00397;PF00413;PF00435;PF00514;PF00594;PF00611;PF00612;PF00618;PF00640;PF00684;PF00688;PF00757;PF00778;PF01030;PF01064;PF01403;PF01437;PF01833;PF02148;PF02185;PF02214;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF10409;PF12348;PF13855;PF14429
Group	GO:0043412	macromolecule modification	1	8.47	2.50e-14	1.09e-12	76|193|602|3527	PF00019;PF00025;PF00027;PF00076;PF00130;PF00134;PF00169;PF00179;PF00240;PF00254;PF00341;PF00397;PF00400;PF00415;PF00514;PF00581;PF00583;PF00594;PF00611;PF00622;PF00640;PF00643;PF00651;PF00688;PF00757;PF00780;PF00786;PF00899;PF00989;PF01030;PF01064;PF01585;PF01753;PF02148;PF02177;PF02185;PF02201;PF02214;PF02225;PF02709;PF02825;PF02845;PF03133;PF03165;PF03256;PF03607;PF04055;PF04762;PF04810;PF05033;PF05773;PF06325;PF07645;PF07653;PF07679;PF07707;PF07719;PF08210;PF10277;PF10409;PF11717;PF12697;PF12796;PF12895;PF12906;PF12924;PF13091;PF13344;PF13646;PF13733;PF13831;PF13832;PF13855;PF13920;PF13964;PF14324
Group	GO:0065008	regulation of biological quality	1	8.44	2.36e-14	1.09e-12	78|193|628|3527	PF00019;PF00024;PF00025;PF00027;PF00057;PF00076;PF00082;PF00093;PF00122;PF00130;PF00153;PF00169;PF00240;PF00241;PF00254;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00583;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00786;PF01064;PF01217;PF01336;PF01403;PF01417;PF01437;PF01477;PF01496;PF01553;PF01699;PF01843;PF02145;PF02148;PF02177;PF02181;PF02214;PF02218;PF02225;PF03165;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF07707;PF08246;PF10409;PF12171;PF12348;PF12756;PF12763;PF12796;PF12924;PF13246;PF13716;PF13855;PF13903;PF14429
Group	GO:0051641	cellular localization	1	8.53	5.31e-14	2.04e-12	67|193|494|3527	PF00019;PF00025;PF00027;PF00053;PF00076;PF00122;PF00130;PF00153;PF00169;PF00179;PF00226;PF00240;PF00341;PF00350;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00786;PF00989;PF01217;PF01403;PF01417;PF01465;PF01843;PF02145;PF02177;PF02181;PF03810;PF04144;PF04695;PF04810;PF07645;PF07653;PF07679;PF07707;PF07719;PF08389;PF09324;PF12171;PF12348;PF12473;PF12756;PF12763;PF12783;PF12796;PF12924;PF13246;PF13385;PF13855;PF13920
Group	GO:0007399	nervous system development	1	8.50	1.95e-13	7.09e-12	58|193|397|3527	PF00019;PF00024;PF00025;PF00052;PF00053;PF00055;PF00057;PF00122;PF00130;PF00169;PF00254;PF00341;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00610;PF00611;PF00612;PF00618;PF00640;PF00651;PF00688;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01437;PF01833;PF02145;PF02148;PF02177;PF02181;PF02377;PF03165;PF03607;PF06367;PF06371;PF07525;PF07645;PF07653;PF07679;PF10409;PF12348;PF12796;PF12924;PF13385;PF13716;PF13855;PF13903;PF14324
Group	GO:0019538	protein metabolic process	1	7.81	2.46e-13	8.47e-12	93|193|869|3527	PF00019;PF00025;PF00027;PF00040;PF00045;PF00057;PF00076;PF00082;PF00122;PF00130;PF00133;PF00134;PF00169;PF00179;PF00226;PF00240;PF00254;PF00341;PF00397;PF00400;PF00413;PF00415;PF00452;PF00514;PF00581;PF00583;PF00594;PF00611;PF00612;PF00622;PF00640;PF00643;PF00651;PF00684;PF00688;PF00702;PF00757;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01336;PF01546;PF01753;PF02148;PF02177;PF02185;PF02201;PF02214;PF02225;PF02709;PF02825;PF02845;PF03133;PF03165;PF03256;PF03607;PF04055;PF04137;PF04810;PF05033;PF05773;PF06325;PF07645;PF07653;PF07679;PF07687;PF07707;PF07719;PF08246;PF08662;PF09409;PF10277;PF10409;PF11717;PF12697;PF12796;PF12895;PF12906;PF12924;PF13344;PF13589;PF13646;PF13733;PF13831;PF13832;PF13855;PF13920;PF13964;PF14324
Group	GO:0040011	locomotion	1	8.58	2.61e-13	8.53e-12	53|193|342|3527	PF00019;PF00024;PF00045;PF00052;PF00053;PF00055;PF00057;PF00098;PF00130;PF00169;PF00226;PF00241;PF00341;PF00397;PF00413;PF00435;PF00514;PF00594;PF00611;PF00612;PF00618;PF00640;PF00651;PF00684;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01437;PF01833;PF02145;PF02148;PF02177;PF02185;PF02214;PF03165;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF10409;PF12348;PF12924;PF13855;PF14429
Group	GO:0051239	regulation of multicellular organismal process	1	8.33	2.76e-13	8.57e-12	62|193|448|3527	PF00019;PF00024;PF00025;PF00027;PF00076;PF00093;PF00122;PF00130;PF00169;PF00240;PF00254;PF00341;PF00400;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00688;PF00689;PF00690;PF00702;PF00778;PF00780;PF00786;PF00969;PF01064;PF01403;PF01417;PF01437;PF01699;PF01753;PF01833;PF01843;PF02177;PF02181;PF02214;PF02377;PF03165;PF03226;PF04055;PF04144;PF06367;PF06371;PF07525;PF07645;PF07653;PF07679;PF08246;PF10409;PF12763;PF12796;PF12924;PF13716;PF13855
Group	GO:0009790	embryo development	1	8.67	2.99e-13	8.88e-12	49|193|299|3527	PF00019;PF00025;PF00052;PF00053;PF00057;PF00076;PF00093;PF00122;PF00130;PF00133;PF00134;PF00169;PF00341;PF00388;PF00400;PF00435;PF00452;PF00514;PF00583;PF00610;PF00612;PF00622;PF00640;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00786;PF00989;PF01030;PF01064;PF01403;PF01417;PF01843;PF02145;PF02185;PF02377;PF03165;PF05033;PF06297;PF07525;PF07645;PF07653;PF07679;PF12796;PF13091
Group	GO:0032990	cell part morphogenesis	1	8.92	4.83e-13	1.37e-11	40|193|210|3527	PF00024;PF00025;PF00052;PF00053;PF00055;PF00130;PF00169;PF00397;PF00400;PF00415;PF00435;PF00514;PF00581;PF00611;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01437;PF01833;PF02148;PF02177;PF02377;PF03133;PF03165;PF03607;PF07645;PF07653;PF07679;PF07719;PF12348;PF12796;PF12924;PF13716;PF13855
Group	GO:0007154	cell communication	1	7.87	5.41e-13	1.47e-11	80|193|691|3527	PF00019;PF00025;PF00027;PF00057;PF00076;PF00082;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00683;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00899;PF00969;PF00989;PF01030;PF01064;PF01217;PF01370;PF01403;PF01417;PF01437;PF01465;PF01833;PF01843;PF02140;PF02145;PF02177;PF02185;PF02214;PF02377;PF02759;PF02825;PF03165;PF05773;PF05790;PF07525;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF10277;PF10409;PF12473;PF12763;PF12796;PF12924;PF13716;PF13855
Group	GO:0023052	signaling	1	7.75	1.52e-12	3.98e-11	76|193|648|3527	PF00019;PF00025;PF00027;PF00057;PF00076;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00683;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF00989;PF01030;PF01064;PF01217;PF01370;PF01403;PF01417;PF01437;PF01465;PF01833;PF01843;PF02140;PF02145;PF02177;PF02185;PF02214;PF02377;PF02759;PF02825;PF03165;PF05790;PF07525;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF10277;PF10409;PF12473;PF12763;PF12796;PF12924;PF13716;PF13855
Group	GO:0050793	regulation of developmental process	1	8.09	1.78e-12	4.48e-11	57|193|405|3527	PF00019;PF00024;PF00025;PF00057;PF00076;PF00093;PF00098;PF00130;PF00134;PF00169;PF00179;PF00241;PF00254;PF00341;PF00400;PF00435;PF00452;PF00514;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00688;PF00778;PF00780;PF00786;PF01064;PF01403;PF01417;PF01437;PF01753;PF01833;PF01843;PF02177;PF02181;PF02185;PF02377;PF03165;PF03226;PF06367;PF06371;PF07525;PF07645;PF07679;PF08246;PF10409;PF12763;PF12796;PF12906;PF12924;PF13716;PF13855
Group	GO:0000902	cell morphogenesis	1	8.28	4.15e-12	1.00e-10	44|193|265|3527	PF00019;PF00024;PF00025;PF00052;PF00053;PF00055;PF00130;PF00169;PF00397;PF00400;PF00415;PF00435;PF00514;PF00581;PF00611;PF00640;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01437;PF01833;PF01843;PF02148;PF02177;PF02377;PF03133;PF03165;PF03607;PF06920;PF07645;PF07653;PF07679;PF07719;PF12348;PF12796;PF12924;PF13716;PF13855
Group	GO:0042221	response to chemical stimulus	1	7.29	2.87e-11	6.45e-10	71|193|615|3527	PF00019;PF00027;PF00040;PF00045;PF00052;PF00053;PF00055;PF00057;PF00076;PF00093;PF00098;PF00122;PF00130;PF00134;PF00153;PF00169;PF00179;PF00226;PF00240;PF00341;PF00388;PF00397;PF00400;PF00413;PF00435;PF00452;PF00514;PF00583;PF00594;PF00612;PF00622;PF00640;PF00651;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00969;PF00989;PF01030;PF01064;PF01370;PF01403;PF01437;PF01833;PF01909;PF02145;PF02148;PF02177;PF02218;PF03165;PF06920;PF07525;PF07645;PF07653;PF07679;PF07719;PF08246;PF08416;PF10409;PF10421;PF12348;PF12796;PF12924;PF13716;PF13855;PF14429
Group	GO:0009605	response to external stimulus	1	7.61	5.28e-11	1.11e-09	48|193|330|3527	PF00019;PF00027;PF00052;PF00053;PF00055;PF00076;PF00082;PF00098;PF00122;PF00341;PF00397;PF00400;PF00435;PF00594;PF00612;PF00618;PF00622;PF00640;PF00651;PF00688;PF00689;PF00690;PF00702;PF00778;PF00780;PF00786;PF00899;PF00969;PF01064;PF01403;PF01437;PF01833;PF02145;PF02148;PF02177;PF03165;PF05773;PF06920;PF07645;PF07679;PF08246;PF10409;PF12348;PF12796;PF12924;PF13091;PF13855;PF14429
Group	GO:0080090	regulation of primary metabolic process	1	6.87	8.61e-11	1.70e-09	87|193|861|3527	PF00019;PF00024;PF00027;PF00057;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00341;PF00389;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00640;PF00643;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01335;PF01336;PF01352;PF01403;PF01437;PF01585;PF01753;PF01833;PF02145;PF02148;PF02177;PF02201;PF02218;PF02377;PF02826;PF02845;PF03165;PF04055;PF04762;PF05033;PF05773;PF06920;PF07525;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08662;PF08711;PF09816;PF11717;PF12171;PF12697;PF12756;PF12763;PF12796;PF12895;PF12924;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324;PF14429
Group	GO:0031323	regulation of cellular metabolic process	1	6.80	1.28e-10	2.46e-09	87|193|867|3527	PF00019;PF00027;PF00057;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00254;PF00341;PF00389;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00611;PF00612;PF00618;PF00640;PF00643;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01336;PF01352;PF01403;PF01437;PF01477;PF01585;PF01753;PF01833;PF02145;PF02148;PF02177;PF02201;PF02218;PF02377;PF02826;PF02845;PF03165;PF04055;PF04762;PF05033;PF05773;PF06920;PF07525;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08662;PF08711;PF09816;PF11717;PF12171;PF12697;PF12756;PF12763;PF12796;PF12895;PF12924;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324;PF14429
Group	GO:0000003	reproduction	1	7.25	1.51e-10	2.76e-09	54|193|412|3527	PF00019;PF00045;PF00053;PF00055;PF00076;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00188;PF00226;PF00240;PF00350;PF00388;PF00400;PF00413;PF00435;PF00452;PF00514;PF00612;PF00618;PF00622;PF00651;PF00684;PF00688;PF00702;PF00757;PF00780;PF00786;PF00989;PF01030;PF01064;PF01335;PF01465;PF01553;PF01753;PF02177;PF02181;PF03165;PF05033;PF06325;PF07525;PF07653;PF07679;PF09335;PF12478;PF12796;PF12924;PF13091;PF13589;PF13855;PF13920
Group	GO:0051716	cellular response to stimulus	1	6.63	3.73e-10	5.95e-09	85|193|853|3527	PF00019;PF00025;PF00027;PF00040;PF00057;PF00076;PF00082;PF00093;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00341;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00583;PF00594;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00643;PF00651;PF00683;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF00786;PF00899;PF00969;PF00989;PF01030;PF01064;PF01336;PF01370;PF01403;PF01417;PF01437;PF01833;PF01843;PF01909;PF02140;PF02145;PF02177;PF02185;PF02377;PF02759;PF02825;PF03165;PF05773;PF05790;PF07525;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF10277;PF10409;PF10421;PF11717;PF12763;PF12796;PF12924;PF13589;PF13716;PF13855;PF14324
Group	GO:0060255	regulation of macromolecule metabolic process	1	6.62	3.68e-10	5.95e-09	86|193|868|3527	PF00019;PF00024;PF00027;PF00057;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00341;PF00389;PF00397;PF00400;PF00415;PF00435;PF00452;PF00514;PF00581;PF00594;PF00610;PF00640;PF00643;PF00651;PF00688;PF00757;PF00778;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01335;PF01336;PF01352;PF01403;PF01437;PF01477;PF01585;PF01753;PF01833;PF02145;PF02148;PF02177;PF02201;PF02218;PF02377;PF02826;PF02845;PF03165;PF04055;PF04762;PF05033;PF05773;PF06325;PF07525;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08246;PF08662;PF08711;PF09816;PF10409;PF11717;PF12171;PF12756;PF12763;PF12796;PF12895;PF12924;PF13091;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324
Group	GO:0007163	establishment or maintenance of cell polarity	1	7.21	2.53e-08	2.85e-07	20|193|88|3527	PF00052;PF00053;PF00057;PF00130;PF00169;PF00400;PF00435;PF00610;PF00612;PF00651;PF00778;PF00786;PF01843;PF02181;PF06367;PF06371;PF07653;PF07679;PF12348;PF13855
Group	GO:0006950	response to stress	1	5.76	5.72e-08	6.02e-07	70|193|709|3527	PF00019;PF00024;PF00027;PF00040;PF00045;PF00057;PF00076;PF00082;PF00093;PF00098;PF00122;PF00130;PF00134;PF00169;PF00179;PF00226;PF00240;PF00341;PF00350;PF00400;PF00413;PF00435;PF00452;PF00581;PF00594;PF00618;PF00622;PF00640;PF00643;PF00651;PF00684;PF00688;PF00689;PF00690;PF00702;PF00757;PF00780;PF00786;PF00899;PF00969;PF00989;PF01030;PF01336;PF01476;PF01477;PF01833;PF01843;PF01909;PF02145;PF02177;PF04055;PF05773;PF05790;PF06920;PF07534;PF07645;PF07653;PF07679;PF08246;PF10277;PF10409;PF10421;PF11717;PF12697;PF12924;PF13589;PF13716;PF13855;PF14324;PF14429
Group	GO:0051234	establishment of localization	1	5.52	1.45e-07	1.42e-06	74|193|785|3527	PF00019;PF00025;PF00027;PF00040;PF00053;PF00057;PF00076;PF00122;PF00130;PF00153;PF00169;PF00179;PF00226;PF00241;PF00254;PF00341;PF00350;PF00388;PF00397;PF00400;PF00435;PF00452;PF00514;PF00581;PF00610;PF00611;PF00612;PF00618;PF00622;PF00640;PF00651;PF00683;PF00688;PF00689;PF00690;PF00702;PF00780;PF00989;PF01064;PF01217;PF01417;PF01465;PF01477;PF01496;PF01553;PF01699;PF01833;PF01843;PF02145;PF02177;PF02214;PF02225;PF03810;PF04144;PF04695;PF04810;PF06472;PF07645;PF07653;PF07679;PF07707;PF07719;PF08246;PF08389;PF09324;PF10277;PF12473;PF12763;PF12783;PF12796;PF12924;PF13246;PF13385;PF13855
Group	GO:0033036	macromolecule localization	1	5.82	1.88e-07	1.81e-06	43|193|354|3527	PF00019;PF00025;PF00052;PF00053;PF00057;PF00076;PF00122;PF00130;PF00169;PF00226;PF00240;PF00241;PF00350;PF00397;PF00400;PF00435;PF00514;PF00581;PF00611;PF00683;PF00688;PF00778;PF01064;PF01217;PF01465;PF01477;PF02145;PF03810;PF04144;PF04695;PF04810;PF06472;PF07645;PF07653;PF07679;PF08389;PF10277;PF10409;PF12348;PF12763;PF12796;PF13246;PF13855
Group	GO:0051171	regulation of nitrogen compound metabolic process	1	5.47	2.74e-07	2.52e-06	64|193|647|3527	PF00019;PF00027;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00226;PF00341;PF00389;PF00397;PF00400;PF00435;PF00514;PF00610;PF00611;PF00612;PF00618;PF00643;PF00651;PF00688;PF00757;PF00780;PF00899;PF00989;PF01030;PF01336;PF01352;PF01403;PF01437;PF01585;PF01753;PF01833;PF02145;PF02177;PF02201;PF02826;PF03165;PF04762;PF05033;PF06920;PF07528;PF07645;PF07653;PF07679;PF07719;PF08210;PF08711;PF09816;PF11717;PF12171;PF12756;PF12796;PF12895;PF12924;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324;PF14429
Group	GO:0002376	immune system process	1	4.99	5.91e-06	3.68e-05	38|193|334|3527	PF00019;PF00057;PF00130;PF00153;PF00169;PF00179;PF00240;PF00254;PF00341;PF00350;PF00388;PF00452;PF00514;PF00594;PF00612;PF00643;PF00651;PF00688;PF00780;PF00969;PF01335;PF01476;PF01909;PF02218;PF04055;PF04810;PF05790;PF07534;PF07645;PF07653;PF07679;PF08246;PF10409;PF10421;PF12697;PF12796;PF13855;PF14324
Group	GO:0009056	catabolic process	1	4.16	6.99e-05	3.21e-04	50|193|543|3527	PF00019;PF00025;PF00082;PF00098;PF00122;PF00134;PF00153;PF00179;PF00205;PF00226;PF00240;PF00350;PF00397;PF00400;PF00452;PF00456;PF00583;PF00612;PF00622;PF00643;PF00688;PF00689;PF00690;PF00702;PF00789;PF00899;PF00970;PF01370;PF01477;PF01546;PF01597;PF01909;PF02148;PF02214;PF02825;PF02845;PF03256;PF03828;PF06472;PF07707;PF08210;PF08246;PF08442;PF09409;PF10409;PF12697;PF12895;PF13589;PF13646;PF13920
Group	GO:0044260	cellular macromolecule metabolic process	1	3.62	2.19e-04	9.00e-04	102|193|1425|3527	PF00019;PF00025;PF00027;PF00057;PF00076;PF00082;PF00098;PF00122;PF00130;PF00133;PF00134;PF00169;PF00179;PF00226;PF00240;PF00254;PF00341;PF00397;PF00400;PF00415;PF00452;PF00514;PF00581;PF00583;PF00594;PF00611;PF00622;PF00640;PF00643;PF00651;PF00684;PF00688;PF00702;PF00757;PF00780;PF00786;PF00789;PF00899;PF00989;PF01030;PF01064;PF01336;PF01370;PF01480;PF01585;PF01753;PF01909;PF02148;PF02177;PF02185;PF02201;PF02214;PF02225;PF02709;PF02825;PF02845;PF02878;PF03133;PF03165;PF03256;PF03607;PF03828;PF04055;PF04137;PF04762;PF04810;PF05033;PF05773;PF06325;PF07034;PF07528;PF07645;PF07653;PF07679;PF07707;PF07719;PF08075;PF08210;PF08662;PF08711;PF09409;PF10277;PF10409;PF11717;PF12171;PF12697;PF12796;PF12895;PF12906;PF12924;PF13091;PF13344;PF13589;PF13646;PF13691;PF13733;PF13831;PF13832;PF13855;PF13920;PF13964;PF14324
Group	GO:0009889	regulation of biosynthetic process	1	3.57	4.59e-04	1.69e-03	54|193|646|3527	PF00019;PF00076;PF00098;PF00130;PF00134;PF00169;PF00179;PF00341;PF00389;PF00397;PF00400;PF00435;PF00514;PF00643;PF00651;PF00688;PF00757;PF00899;PF00989;PF01030;PF01064;PF01336;PF01352;PF01585;PF01753;PF01833;PF02177;PF02201;PF02826;PF03165;PF04762;PF05033;PF05773;PF07528;PF07645;PF07679;PF07719;PF08210;PF08662;PF08711;PF09816;PF11717;PF12171;PF12756;PF12796;PF12895;PF12924;PF13716;PF13831;PF13832;PF13854;PF13855;PF13920;PF14324
Group	GO:0001932	regulation of protein phosphorylation	2	10.31	1.18e-15	9.66e-14	39|193|169|3527	PF00019;PF00027;PF00057;PF00134;PF00169;PF00226;PF00240;PF00341;PF00400;PF00415;PF00452;PF00581;PF00594;PF00610;PF00640;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF01403;PF01437;PF01585;PF02145;PF02177;PF02218;PF02377;PF04055;PF07525;PF07645;PF07653;PF07679;PF12796;PF12924;PF13716;PF13855;PF13920
Group	GO:0035556	intracellular signal transduction	2	9.63	2.50e-14	1.09e-12	39|193|184|3527	PF00025;PF00027;PF00098;PF00122;PF00130;PF00134;PF00169;PF00240;PF00397;PF00400;PF00435;PF00452;PF00581;PF00610;PF00611;PF00612;PF00618;PF00640;PF00643;PF00651;PF00689;PF00690;PF00702;PF00780;PF00786;PF01843;PF02145;PF02185;PF02759;PF07525;PF07645;PF07653;PF07679;PF08246;PF10277;PF10409;PF12763;PF13716;PF13855
Group	GO:0016477	cell migration	2	9.59	3.03e-14	1.24e-12	39|193|185|3527	PF00019;PF00045;PF00052;PF00053;PF00055;PF00057;PF00130;PF00341;PF00397;PF00413;PF00435;PF00594;PF00611;PF00612;PF00618;PF00640;PF00688;PF00757;PF00778;PF01030;PF01064;PF01403;PF01437;PF01833;PF02148;PF02185;PF02214;PF03607;PF06297;PF06367;PF06371;PF06920;PF07645;PF07653;PF07679;PF10409;PF12348;PF13855;PF14429
Group	GO:0051130	positive regulation of cellular component organization	2	8.89	1.64e-11	3.81e-10	26|193|104|3527	PF00019;PF00025;PF00241;PF00341;PF00397;PF00400;PF00452;PF00514;PF00594;PF00611;PF00688;PF00786;PF01064;PF01403;PF01437;PF02181;PF02185;PF03165;PF06367;PF06371;PF07653;PF07679;PF07719;PF12796;PF13091;PF13855
Group	GO:0042060	wound healing	2	8.86	4.64e-11	1.01e-09	23|193|85|3527	PF00024;PF00027;PF00093;PF00122;PF00130;PF00169;PF00341;PF00435;PF00594;PF00618;PF00622;PF00643;PF00689;PF00690;PF00702;PF00757;PF00786;PF01030;PF06920;PF07653;PF07679;PF13716;PF14429
Group	GO:0051301	cell division	2	8.60	8.34e-11	1.70e-09	24|193|95|3527	PF00019;PF00025;PF00076;PF00130;PF00134;PF00169;PF00241;PF00350;PF00435;PF00452;PF00514;PF00612;PF00640;PF00651;PF00688;PF00780;PF00786;PF01064;PF02181;PF03165;PF06367;PF06371;PF07707;PF13964
Group	GO:0060541	respiratory system development	2	8.60	1.52e-10	2.76e-09	22|193|82|3527	PF00019;PF00045;PF00057;PF00130;PF00240;PF00341;PF00413;PF00435;PF00640;PF00688;PF01064;PF02181;PF03165;PF06367;PF06371;PF07645;PF07653;PF07679;PF08246;PF10409;PF13855;PF13903
Group	GO:0051056	regulation of small GTPase mediated signal transduction	2	8.67	2.39e-10	4.22e-09	20|193|69|3527	PF00130;PF00169;PF00610;PF00611;PF00612;PF00618;PF00651;PF00780;PF01403;PF01437;PF01833;PF02145;PF02214;PF06920;PF07653;PF07679;PF12796;PF13716;PF13855;PF14429
Group	GO:0018193	peptidyl-amino acid modification	2	7.86	2.88e-10	4.95e-09	30|193|153|3527	PF00130;PF00169;PF00240;PF00254;PF00341;PF00397;PF00400;PF00581;PF00583;PF00594;PF00611;PF00757;PF00899;PF01030;PF01753;PF02709;PF03133;PF04810;PF05033;PF06325;PF07645;PF07679;PF07719;PF11717;PF12796;PF13646;PF13733;PF13831;PF13832;PF13855
Group	GO:0030198	extracellular matrix organization	2	8.69	3.24e-10	5.43e-09	19|193|63|3527	PF00019;PF00045;PF00052;PF00053;PF00055;PF00057;PF00093;PF00397;PF00413;PF00640;PF00688;PF02177;PF02709;PF04810;PF07679;PF12924;PF13716;PF13733;PF13855
Group	GO:0006508	proteolysis	2	7.49	8.36e-10	1.30e-08	32|193|179|3527	PF00040;PF00045;PF00057;PF00076;PF00082;PF00134;PF00179;PF00226;PF00240;PF00397;PF00400;PF00413;PF00452;PF00594;PF00612;PF00622;PF00643;PF00789;PF01546;PF02148;PF02214;PF02225;PF02825;PF02845;PF03256;PF07687;PF07707;PF08246;PF12895;PF13589;PF13646;PF13920
Group	GO:0010740	positive regulation of intracellular protein kinase cascade	2	8.24	9.57e-10	1.45e-08	20|193|74|3527	PF00019;PF00122;PF00130;PF00179;PF00240;PF00341;PF00594;PF00688;PF00689;PF00690;PF00702;PF00757;PF00778;PF00780;PF01030;PF02218;PF07653;PF07679;PF12763;PF13920
Group	GO:0031329	regulation of cellular catabolic process	2	7.80	1.06e-09	1.58e-08	25|193|115|3527	PF00027;PF00076;PF00130;PF00169;PF00226;PF00240;PF00400;PF00514;PF00610;PF00611;PF00612;PF00618;PF00778;PF00780;PF00789;PF01403;PF01437;PF02145;PF02148;PF06920;PF07653;PF12697;PF13716;PF13855;PF14429
Group	GO:0032446	protein modification by small protein conjugation	2	7.74	1.29e-09	1.87e-08	25|193|116|3527	PF00179;PF00240;PF00397;PF00415;PF00514;PF00622;PF00643;PF00651;PF00899;PF02148;PF02201;PF02214;PF02225;PF02825;PF02845;PF03256;PF05773;PF07707;PF07719;PF12796;PF12895;PF12906;PF13920;PF13964;PF14324
Group	GO:0043549	regulation of kinase activity	2	7.57	1.57e-09	2.22e-08	27|193|135|3527	PF00019;PF00027;PF00134;PF00169;PF00240;PF00341;PF00400;PF00415;PF00581;PF00640;PF00688;PF00778;PF00780;PF00786;PF01585;PF02145;PF02177;PF04055;PF07525;PF07645;PF07653;PF07679;PF12796;PF12924;PF13716;PF13855;PF13920
Group	GO:0007444	imaginal disc development	2	7.84	3.38e-09	4.69e-08	20|193|79|3527	PF00045;PF00076;PF00130;PF00397;PF00413;PF00435;PF00612;PF00651;PF01064;PF01476;PF01833;PF03165;PF07534;PF07645;PF07653;PF07679;PF12796;PF13855;PF13920;PF14324
Group	GO:0006461	protein complex assembly	2	7.11	4.15e-09	5.64e-08	31|193|180|3527	PF00019;PF00025;PF00093;PF00130;PF00134;PF00169;PF00179;PF00350;PF00400;PF00452;PF00611;PF00622;PF00643;PF00688;PF00757;PF00778;PF00969;PF01030;PF01064;PF02148;PF02181;PF02214;PF03165;PF04695;PF06309;PF06367;PF06371;PF07645;PF07679;PF07719;PF12763
Group	GO:0002165	instar larval or pupal development	2	7.69	5.43e-09	7.23e-08	20|193|81|3527	PF00045;PF00076;PF00130;PF00397;PF00413;PF00435;PF00514;PF00612;PF00651;PF01064;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF10409;PF12796;PF13855;PF13920
Group	GO:0007552	metamorphosis	2	7.72	6.63e-09	8.66e-08	19|193|74|3527	PF00045;PF00076;PF00130;PF00397;PF00413;PF00435;PF00612;PF00651;PF01064;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF10409;PF12796;PF13855;PF13920
Group	GO:0060341	regulation of cellular localization	2	7.06	9.59e-09	1.23e-07	27|193|146|3527	PF00019;PF00027;PF00076;PF00098;PF00169;PF00514;PF00594;PF00610;PF00612;PF00618;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF01064;PF01833;PF01843;PF02214;PF04055;PF04144;PF04810;PF12796;PF13091;PF13716;PF13855
Group	GO:0008360	regulation of cell shape	2	7.76	1.12e-08	1.41e-07	17|193|61|3527	PF00024;PF00130;PF00169;PF00341;PF00611;PF00612;PF00618;PF00780;PF00786;PF01403;PF01437;PF01843;PF02181;PF06367;PF06371;PF07679;PF10409
Group	GO:0051235	maintenance of location	2	8.28	1.35e-08	1.66e-07	13|193|35|3527	PF00122;PF00241;PF00400;PF00435;PF00683;PF00689;PF00690;PF00702;PF07645;PF12171;PF12348;PF12756;PF12796
Group	GO:0021700	developmental maturation	2	7.52	1.66e-08	2.00e-07	18|193|70|3527	PF00019;PF00076;PF00130;PF00134;PF00169;PF00435;PF00622;PF00651;PF00688;PF01833;PF01843;PF02177;PF07525;PF07679;PF12796;PF12924;PF13091;PF13855
Group	GO:0032270	positive regulation of cellular protein metabolic process	2	6.95	1.70e-08	2.01e-07	26|193|140|3527	PF00019;PF00057;PF00076;PF00134;PF00179;PF00240;PF00341;PF00400;PF00594;PF00640;PF00688;PF00757;PF00778;PF00780;PF00786;PF01030;PF01064;PF02218;PF02845;PF07645;PF07653;PF07679;PF07719;PF12763;PF13855;PF14324
Group	GO:2000145	regulation of cell motility	2	7.14	1.99e-08	2.32e-07	22|193|104|3527	PF00019;PF00045;PF00055;PF00093;PF00130;PF00341;PF00388;PF00413;PF00688;PF00757;PF01030;PF01403;PF01437;PF01833;PF02185;PF07645;PF07653;PF07679;PF08246;PF10409;PF13716;PF13855
Group	GO:0009886	post-embryonic morphogenesis	2	7.21	2.53e-08	2.85e-07	20|193|88|3527	PF00045;PF00076;PF00130;PF00397;PF00413;PF00435;PF00452;PF00612;PF00651;PF01064;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF10409;PF12796;PF13855;PF13920
Group	GO:0006468	protein phosphorylation	2	6.75	4.08e-08	4.51e-07	25|193|136|3527	PF00019;PF00027;PF00130;PF00134;PF00169;PF00240;PF00341;PF00611;PF00640;PF00688;PF00757;PF00780;PF00786;PF00989;PF01030;PF01064;PF02177;PF02185;PF03165;PF03607;PF07645;PF07653;PF07679;PF12924;PF13855
Group	GO:0051640	organelle localization	2	6.93	4.91e-08	5.34e-07	21|193|100|3527	PF00130;PF00169;PF00350;PF00388;PF00400;PF00435;PF00612;PF00640;PF00651;PF00780;PF00786;PF01403;PF01843;PF02181;PF04810;PF07707;PF07719;PF12171;PF12473;PF12756;PF13920
Group	GO:0051241	negative regulation of multicellular organismal process	2	7.23	5.27e-08	5.64e-07	17|193|67|3527	PF00019;PF00122;PF00169;PF00240;PF00341;PF00594;PF00651;PF00688;PF00689;PF00690;PF00702;PF00969;PF01699;PF07525;PF07645;PF10409;PF12796
Group	GO:0035239	tube morphogenesis	2	6.81	5.88e-08	6.09e-07	22|193|110|3527	PF00019;PF00045;PF00130;PF00341;PF00400;PF00413;PF00435;PF00514;PF00651;PF00688;PF00786;PF00989;PF01403;PF01437;PF02145;PF03165;PF05033;PF07653;PF07679;PF07707;PF08246;PF13855
Group	GO:0001763	morphogenesis of a branching structure	2	7.15	6.69e-08	6.83e-07	17|193|68|3527	PF00019;PF00045;PF00130;PF00341;PF00413;PF00435;PF00688;PF00786;PF01064;PF01403;PF01437;PF01833;PF07645;PF07653;PF07679;PF08246;PF13855
Group	GO:0030163	protein catabolic process	2	6.65	9.80e-08	9.69e-07	22|193|113|3527	PF00082;PF00134;PF00179;PF00226;PF00240;PF00397;PF00400;PF00452;PF00622;PF00643;PF00789;PF02148;PF02214;PF02825;PF02845;PF03256;PF07707;PF09409;PF12895;PF13589;PF13646;PF13920
Group	GO:0009968	negative regulation of signal transduction	2	6.41	9.65e-08	9.69e-07	27|193|162|3527	PF00019;PF00057;PF00093;PF00130;PF00169;PF00400;PF00514;PF00581;PF00640;PF00651;PF00683;PF00688;PF00778;PF01585;PF01833;PF02145;PF02214;PF03165;PF03226;PF07525;PF07645;PF07679;PF10409;PF12763;PF12796;PF13855;PF14324
Group	GO:0044057	regulation of system process	2	6.40	2.20e-07	2.08e-06	22|193|118|3527	PF00019;PF00027;PF00122;PF00130;PF00169;PF00254;PF00341;PF00435;PF00514;PF00618;PF00688;PF00689;PF00690;PF00702;PF01699;PF01833;PF02214;PF03226;PF07653;PF07679;PF12796;PF13855
Group	GO:0048569	post-embryonic organ development	2	6.55	2.46e-07	2.29e-06	19|193|91|3527	PF00045;PF00076;PF00130;PF00397;PF00413;PF00435;PF00452;PF00612;PF00651;PF01064;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF12796;PF13855;PF13920
Group	GO:0048737	imaginal disc-derived appendage development	2	6.79	3.25e-07	2.93e-06	15|193|59|3527	PF00076;PF00130;PF00397;PF00435;PF00612;PF00651;PF01064;PF01476;PF01833;PF03165;PF07534;PF07645;PF12796;PF13855;PF13920
Group	GO:0046903	secretion	2	6.33	3.27e-07	2.93e-06	21|193|111|3527	PF00019;PF00025;PF00027;PF00122;PF00130;PF00169;PF00341;PF00610;PF00612;PF00618;PF00640;PF00683;PF00688;PF00702;PF01217;PF01417;PF01553;PF04144;PF07645;PF07679;PF12763
Group	GO:0009798	axis specification	2	6.85	3.79e-07	3.35e-06	14|193|52|3527	PF00057;PF00076;PF00130;PF00400;PF00612;PF00622;PF00651;PF00778;PF01064;PF03165;PF05033;PF06297;PF07525;PF13091
Group	GO:0007292	female gamete generation	2	6.55	3.85e-07	3.35e-06	17|193|76|3527	PF00076;PF00130;PF00134;PF00350;PF00435;PF00514;PF00612;PF00618;PF00622;PF00651;PF01064;PF03165;PF07525;PF07653;PF07679;PF13091;PF13920
Group	GO:0035107	appendage morphogenesis	2	6.37	4.22e-07	3.62e-06	19|193|94|3527	PF00057;PF00076;PF00130;PF00397;PF00435;PF00452;PF00612;PF00651;PF01064;PF01476;PF01833;PF03165;PF07534;PF07645;PF07679;PF07719;PF12796;PF13855;PF13920
Group	GO:1900542	regulation of purine nucleotide metabolic process	2	6.38	5.00e-07	4.20e-06	18|193|86|3527	PF00027;PF00130;PF00169;PF00226;PF00514;PF00610;PF00611;PF00612;PF00618;PF00780;PF01403;PF01437;PF02145;PF06920;PF07653;PF13716;PF13855;PF14429
Group	GO:0051345	positive regulation of hydrolase activity	2	6.31	5.02e-07	4.20e-06	19|193|95|3527	PF00019;PF00025;PF00130;PF00169;PF00226;PF00452;PF00514;PF00610;PF00611;PF00612;PF00643;PF00688;PF02145;PF06920;PF07679;PF08246;PF13716;PF13920;PF14429
Group	GO:0007268	synaptic transmission	2	5.95	6.97e-07	5.76e-06	24|193|146|3527	PF00025;PF00122;PF00130;PF00169;PF00435;PF00622;PF00640;PF00651;PF00690;PF00786;PF01064;PF01217;PF01417;PF02177;PF02214;PF03165;PF07653;PF07679;PF07707;PF12473;PF12763;PF12796;PF12924;PF13855
Group	GO:0001558	regulation of cell growth	2	6.39	7.75e-07	6.33e-06	16|193|71|3527	PF00019;PF00134;PF00179;PF00226;PF00435;PF00640;PF00643;PF00688;PF00757;PF01030;PF01403;PF01437;PF07679;PF10409;PF12796;PF13855
Group	GO:0007411	axon guidance	2	6.28	8.42e-07	6.70e-06	17|193|80|3527	PF00052;PF00397;PF00435;PF00651;PF00778;PF00780;PF01064;PF01403;PF01437;PF01833;PF02148;PF02177;PF03165;PF07645;PF07679;PF12924;PF13855
Group	GO:0051240	positive regulation of multicellular organismal process	2	6.14	8.34e-07	6.70e-06	19|193|98|3527	PF00019;PF00027;PF00122;PF00130;PF00169;PF00341;PF00594;PF00688;PF00689;PF00690;PF00702;PF01064;PF01699;PF04055;PF07645;PF07679;PF12796;PF13716;PF13855
Group	GO:0010562	positive regulation of phosphorus metabolic process	2	6.09	9.83e-07	7.74e-06	19|193|99|3527	PF00019;PF00057;PF00134;PF00240;PF00341;PF00594;PF00640;PF00688;PF00778;PF00780;PF00786;PF01064;PF01403;PF02218;PF07645;PF07653;PF07679;PF12763;PF13855
Group	GO:0010975	regulation of neuron projection development	2	6.38	1.02e-06	7.83e-06	15|193|64|3527	PF00025;PF00254;PF00435;PF00611;PF00780;PF01403;PF01437;PF01833;PF02181;PF06367;PF06371;PF07679;PF10409;PF12796;PF13855
Group	GO:0050817	coagulation	2	6.38	1.02e-06	7.83e-06	15|193|64|3527	PF00024;PF00027;PF00093;PF00122;PF00130;PF00169;PF00341;PF00594;PF00618;PF00689;PF00690;PF00702;PF06920;PF07679;PF14429
Group	GO:0030097	hemopoiesis	2	6.00	1.07e-06	8.09e-06	20|193|109|3527	PF00019;PF00130;PF00153;PF00169;PF00341;PF00452;PF00514;PF00612;PF00643;PF00651;PF00688;PF00780;PF02218;PF04055;PF05790;PF07645;PF07679;PF12796;PF13855;PF14324
Group	GO:0031532	actin cytoskeleton reorganization	2	7.56	1.11e-06	8.30e-06	8|193|17|3527	PF00122;PF00130;PF00612;PF00640;PF00689;PF00690;PF00702;PF00780
Group	GO:0016358	dendrite development	2	6.53	1.21e-06	9.00e-06	13|193|49|3527	PF00024;PF00053;PF00435;PF00640;PF00780;PF00786;PF01064;PF02177;PF03607;PF07653;PF07679;PF12796;PF12924
Group	GO:0060627	regulation of vesicle-mediated transport	2	6.39	1.29e-06	9.48e-06	14|193|57|3527	PF00169;PF00341;PF00397;PF00400;PF00594;PF00610;PF00611;PF00618;PF01833;PF02145;PF04144;PF07645;PF13091;PF13920
Group	GO:0007610	behavior	2	5.75	1.32e-06	9.56e-06	24|193|151|3527	PF00027;PF00057;PF00076;PF00122;PF00130;PF00397;PF00435;PF00612;PF00640;PF00651;PF00689;PF00690;PF00702;PF00970;PF00989;PF01465;PF01699;PF02177;PF02214;PF07653;PF12796;PF12924;PF13716;PF13855
Group	GO:0008544	epidermis development	2	6.17	1.41e-06	1.01e-05	16|193|74|3527	PF00019;PF00093;PF00122;PF00400;PF00514;PF00612;PF00622;PF00688;PF00689;PF00702;PF00757;PF01030;PF01843;PF07679;PF12796;PF13855
Group	GO:0048610	cellular process involved in reproduction	2	5.55	1.68e-06	1.19e-05	28|193|197|3527	PF00019;PF00076;PF00098;PF00130;PF00134;PF00179;PF00240;PF00350;PF00388;PF00435;PF00452;PF00612;PF00622;PF00651;PF00688;PF00786;PF01064;PF01753;PF03165;PF05033;PF06325;PF07525;PF07653;PF07679;PF12796;PF13091;PF13589;PF13920
Group	GO:0034330	cell junction organization	2	6.15	1.91e-06	1.34e-05	15|193|67|3527	PF00019;PF00052;PF00053;PF00055;PF00130;PF00169;PF00435;PF00514;PF00640;PF00688;PF00786;PF07645;PF07653;PF07679;PF13903
Group	GO:0051347	positive regulation of transferase activity	2	5.97	2.47e-06	1.70e-05	16|193|77|3527	PF00019;PF00057;PF00134;PF00169;PF00240;PF00341;PF00400;PF00640;PF00688;PF00778;PF00780;PF00786;PF07645;PF07653;PF07679;PF13855
Group	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	2	5.90	2.46e-06	1.70e-05	17|193|86|3527	PF00019;PF00130;PF00169;PF00341;PF00388;PF00618;PF00640;PF00688;PF00757;PF01030;PF02145;PF07525;PF07645;PF07653;PF07679;PF10409;PF13855
Group	GO:0060560	developmental growth involved in morphogenesis	2	6.13	2.52e-06	1.71e-05	14|193|60|3527	PF00019;PF00057;PF00130;PF00688;PF00786;PF01064;PF01843;PF02177;PF03607;PF07653;PF07679;PF12796;PF12924;PF13855
Group	GO:0007600	sensory perception	2	5.80	2.75e-06	1.83e-05	18|193|96|3527	PF00024;PF00027;PF00053;PF00055;PF00122;PF00350;PF00415;PF00612;PF00689;PF00690;PF00702;PF01477;PF03607;PF07653;PF07679;PF07719;PF12796;PF13385
Group	GO:0045597	positive regulation of cell differentiation	2	5.69	3.75e-06	2.45e-05	18|193|98|3527	PF00019;PF00093;PF00098;PF00130;PF00341;PF00400;PF00514;PF00640;PF00688;PF01064;PF01403;PF01437;PF03165;PF07525;PF07645;PF07679;PF12796;PF13855
Group	GO:0023061	signal release	2	5.98	3.83e-06	2.48e-05	14|193|62|3527	PF00019;PF00025;PF00027;PF00130;PF00169;PF00610;PF00618;PF00640;PF00683;PF00688;PF01217;PF01417;PF07645;PF12763
Group	GO:0016049	cell growth	2	6.06	4.01e-06	2.57e-05	13|193|54|3527	PF00130;PF00651;PF00786;PF01064;PF01843;PF02177;PF03607;PF07679;PF07707;PF12796;PF12924;PF13716;PF13855
Group	GO:0010769	regulation of cell morphogenesis involved in differentiation	2	5.90	4.69e-06	2.97e-05	14|193|63|3527	PF00019;PF00435;PF00514;PF00688;PF00780;PF01403;PF01437;PF01833;PF02181;PF03165;PF06367;PF06371;PF07679;PF13855
Group	GO:0050878	regulation of body fluid levels	2	5.66	5.91e-06	3.68e-05	16|193|82|3527	PF00024;PF00027;PF00093;PF00122;PF00130;PF00169;PF00341;PF00594;PF00618;PF00689;PF00690;PF00702;PF01553;PF06920;PF07679;PF14429
Group	GO:0051248	negative regulation of protein metabolic process	2	5.40	6.64e-06	4.09e-05	20|193|122|3527	PF00019;PF00076;PF00098;PF00134;PF00226;PF00240;PF00400;PF00452;PF00581;PF00688;PF00789;PF01335;PF01585;PF02145;PF02148;PF05773;PF07525;PF12796;PF13716;PF13920
Group	GO:0032535	regulation of cellular component size	2	5.75	6.94e-06	4.23e-05	14|193|65|3527	PF00130;PF00169;PF00241;PF00400;PF00435;PF00786;PF01403;PF01437;PF02145;PF02181;PF07653;PF07679;PF10409;PF13855
Group	GO:0071310	cellular response to organic substance	2	5.04	8.07e-06	4.83e-05	30|193|237|3527	PF00019;PF00076;PF00093;PF00098;PF00130;PF00169;PF00179;PF00226;PF00240;PF00341;PF00400;PF00452;PF00514;PF00583;PF00622;PF00640;PF00688;PF00757;PF00969;PF01030;PF01064;PF01909;PF03165;PF07525;PF07653;PF07679;PF07719;PF10409;PF10421;PF13855
Group	GO:0043408	regulation of MAPK cascade	2	5.54	8.20e-06	4.87e-05	16|193|84|3527	PF00130;PF00169;PF00341;PF00397;PF00514;PF00581;PF00640;PF00757;PF00778;PF00780;PF00786;PF01030;PF01843;PF07653;PF07679;PF13855
Group	GO:0001654	eye development	2	5.34	8.94e-06	5.12e-05	19|193|114|3527	PF00019;PF00053;PF00130;PF00400;PF00415;PF00452;PF00514;PF00612;PF00618;PF00651;PF00688;PF01064;PF01843;PF03607;PF07679;PF10409;PF13716;PF13920;PF14324
Group	GO:0042176	regulation of protein catabolic process	2	5.94	9.52e-06	5.36e-05	11|193|42|3527	PF00240;PF00397;PF00400;PF00514;PF00778;PF00789;PF01335;PF02148;PF07525;PF13920;PF14324
Group	GO:0003002	regionalization	2	5.21	1.02e-05	5.65e-05	21|193|136|3527	PF00019;PF00057;PF00076;PF00093;PF00130;PF00400;PF00514;PF00612;PF00622;PF00651;PF00688;PF00778;PF01064;PF02377;PF03165;PF05033;PF06297;PF07525;PF07679;PF12796;PF13091
Group	GO:0044087	regulation of cellular component biogenesis	2	5.34	1.04e-05	5.70e-05	18|193|105|3527	PF00025;PF00130;PF00241;PF00341;PF00400;PF00452;PF00611;PF00612;PF00622;PF00786;PF01064;PF02181;PF03165;PF06367;PF06371;PF07653;PF10409;PF12796
Group	GO:0043269	regulation of ion transport	2	5.42	1.13e-05	6.13e-05	16|193|86|3527	PF00122;PF00169;PF00254;PF00341;PF00397;PF00435;PF00452;PF00514;PF00594;PF00622;PF00689;PF00690;PF00702;PF07653;PF12796;PF13903
Group	GO:0048638	regulation of developmental growth	2	5.46	1.45e-05	7.81e-05	14|193|69|3527	PF00019;PF00134;PF00179;PF00435;PF00611;PF00612;PF00622;PF00688;PF01064;PF01403;PF01437;PF03165;PF07679;PF13855
Group	GO:2000027	regulation of organ morphogenesis	2	5.49	1.69e-05	8.98e-05	13|193|61|3527	PF00019;PF00400;PF00452;PF00514;PF00610;PF00640;PF00688;PF00778;PF01064;PF02377;PF03165;PF07679;PF12796
Group	GO:0034762	regulation of transmembrane transport	2	5.28	1.94e-05	1.02e-04	15|193|80|3527	PF00019;PF00254;PF00341;PF00397;PF00514;PF00622;PF00688;PF00757;PF00778;PF01030;PF07653;PF12796;PF13716;PF13855;PF13903
Group	GO:0007346	regulation of mitotic cell cycle	2	5.14	2.08e-05	1.09e-04	17|193|100|3527	PF00019;PF00076;PF00130;PF00134;PF00341;PF00397;PF00452;PF00640;PF00688;PF02148;PF02177;PF07653;PF07679;PF12796;PF12895;PF12924;PF14324
Group	GO:0030900	forebrain development	2	5.22	2.27e-05	1.17e-04	15|193|81|3527	PF00019;PF00057;PF00640;PF00688;PF00757;PF01030;PF01064;PF02177;PF03165;PF03607;PF07645;PF07679;PF12924;PF13716;PF13855
Group	GO:0051494	negative regulation of cytoskeleton organization	2	5.68	2.35e-05	1.20e-04	10|193|38|3527	PF00241;PF00254;PF00400;PF00435;PF00514;PF00622;PF00643;PF07653;PF12348;PF12796
Group	GO:0007015	actin filament organization	2	5.34	2.45e-05	1.24e-04	13|193|63|3527	PF00241;PF00400;PF00611;PF00612;PF01064;PF01417;PF02181;PF02214;PF06367;PF06371;PF07653;PF10409;PF12796
Group	GO:0010564	regulation of cell cycle process	2	4.91	3.10e-05	1.55e-04	19|193|124|3527	PF00019;PF00076;PF00130;PF00134;PF00240;PF00341;PF00397;PF00400;PF00452;PF00514;PF00640;PF00688;PF01336;PF02148;PF02185;PF07679;PF12796;PF12895;PF14324
Group	GO:0045786	negative regulation of cell cycle	2	5.29	3.40e-05	1.68e-04	12|193|56|3527	PF00019;PF00134;PF00350;PF00397;PF00640;PF00688;PF01477;PF02148;PF07645;PF07653;PF07679;PF10409
Group	GO:0030031	cell projection assembly	2	5.21	4.11e-05	2.01e-04	12|193|57|3527	PF00169;PF00341;PF00400;PF00581;PF00610;PF00612;PF00778;PF01833;PF02377;PF03133;PF03607;PF07719
Group	GO:0042981	regulation of apoptotic process	2	4.47	5.66e-05	2.66e-04	28|193|236|3527	PF00019;PF00024;PF00082;PF00130;PF00169;PF00240;PF00341;PF00397;PF00452;PF00514;PF00594;PF00640;PF00643;PF00688;PF00757;PF01030;PF01064;PF01335;PF01585;PF07653;PF07679;PF08246;PF10277;PF10409;PF12763;PF13716;PF13855;PF13920
Group	GO:0044265	cellular macromolecule catabolic process	2	4.55	5.72e-05	2.67e-04	24|193|187|3527	PF00082;PF00098;PF00134;PF00179;PF00226;PF00240;PF00397;PF00400;PF00452;PF00622;PF00643;PF00789;PF01909;PF02148;PF02214;PF02825;PF02845;PF03256;PF03828;PF07707;PF12895;PF13589;PF13646;PF13920
Group	GO:0016569	covalent chromatin modification	2	4.71	6.05e-05	2.80e-04	18|193|119|3527	PF00076;PF00130;PF00134;PF00179;PF00254;PF00397;PF00400;PF00583;PF00622;PF01753;PF02148;PF05033;PF06325;PF07719;PF11717;PF12796;PF13831;PF13832
Group	GO:0051051	negative regulation of transport	2	4.99	7.03e-05	3.21e-04	12|193|60|3527	PF00019;PF00130;PF00397;PF00400;PF00611;PF00622;PF00688;PF01064;PF01833;PF04055;PF12796;PF13716
Group	GO:0051216	cartilage development	2	5.16	7.49e-05	3.40e-04	10|193|43|3527	PF00019;PF00052;PF00053;PF00057;PF00093;PF00688;PF01064;PF03165;PF07645;PF07679
Group	GO:0008285	negative regulation of cell proliferation	2	4.70	7.92e-05	3.57e-04	16|193|100|3527	PF00019;PF00350;PF00514;PF00688;PF00786;PF00969;PF01753;PF02145;PF02709;PF03165;PF06297;PF07679;PF07719;PF10409;PF13716;PF13733
Group	GO:0030705	cytoskeleton-dependent intracellular transport	2	4.97	1.13e-04	4.99e-04	10|193|45|3527	PF00169;PF00400;PF00435;PF00612;PF00989;PF01217;PF02177;PF07719;PF12473;PF12924
Group	GO:0051050	positive regulation of transport	2	4.58	1.21e-04	5.32e-04	15|193|93|3527	PF00019;PF00040;PF00076;PF00169;PF00341;PF00397;PF00400;PF00452;PF00594;PF00688;PF00969;PF04144;PF12796;PF13091;PF13855
Group	GO:0001822	kidney development	2	4.68	1.24e-04	5.40e-04	13|193|73|3527	PF00019;PF00025;PF00240;PF00341;PF00400;PF00452;PF00612;PF00651;PF00688;PF07679;PF07707;PF08246;PF13716
Group	GO:0030155	regulation of cell adhesion	2	4.57	1.43e-04	6.15e-04	14|193|84|3527	PF00019;PF00093;PF00130;PF00169;PF00341;PF00612;PF00651;PF00688;PF01064;PF07645;PF07653;PF07679;PF10409;PF13716
Group	GO:0007369	gastrulation	2	4.70	1.68e-04	7.09e-04	11|193|56|3527	PF00019;PF00025;PF00076;PF00130;PF00435;PF00583;PF00688;PF00778;PF01064;PF03165;PF06297
Group	GO:0000278	mitotic cell cycle	2	4.24	2.16e-04	8.93e-04	18|193|131|3527	PF00019;PF00130;PF00134;PF00179;PF00400;PF00452;PF00581;PF00688;PF00780;PF01336;PF01833;PF02148;PF02177;PF07679;PF12348;PF12895;PF12924;PF14324
Group	GO:0031110	regulation of microtubule polymerization or depolymerization	2	4.88	2.35e-04	9.51e-04	8|193|32|3527	PF00025;PF00254;PF00435;PF00514;PF00622;PF00643;PF12348;PF12796
Group	GO:0050890	cognition	2	4.56	2.34e-04	9.51e-04	11|193|58|3527	PF00057;PF00122;PF00397;PF00689;PF00690;PF00702;PF01699;PF02177;PF07653;PF12924;PF13716
Group	GO:0007283	spermatogenesis	2	4.40	2.49e-04	9.96e-04	13|193|78|3527	PF00179;PF00226;PF00240;PF00350;PF00452;PF00612;PF00651;PF00684;PF00780;PF01753;PF07679;PF12796;PF13091
Group	GO:0012501	programmed cell death	2	4.16	2.47e-04	9.96e-04	19|193|144|3527	PF00027;PF00130;PF00240;PF00452;PF00514;PF00651;PF00757;PF00786;PF00989;PF01030;PF01335;PF02177;PF07653;PF08246;PF10409;PF12924;PF13716;PF13855;PF13920
Group	GO:0036075	replacement ossification	2	5.21	2.65e-04	1.04e-03	6|193|18|3527	PF00019;PF00052;PF00053;PF00057;PF00688;PF07679
Group	GO:0044092	negative regulation of molecular function	2	4.09	2.97e-04	1.15e-03	19|193|146|3527	PF00076;PF00134;PF00169;PF00254;PF00397;PF00400;PF00452;PF00581;PF00594;PF00688;PF01585;PF02145;PF02148;PF07525;PF07653;PF09324;PF12796;PF13716;PF13920
Group	GO:0007018	microtubule-based movement	2	4.42	3.19e-04	1.23e-03	11|193|60|3527	PF00169;PF00400;PF00435;PF00612;PF00989;PF01217;PF02177;PF03133;PF07719;PF12473;PF12924
Group	GO:0032880	regulation of protein localization	2	4.29	3.22e-04	1.23e-03	13|193|80|3527	PF00019;PF00514;PF00622;PF00688;PF00757;PF00778;PF00969;PF01030;PF04055;PF04144;PF12796;PF13716;PF13855
Group	GO:0034621	cellular macromolecular complex subunit organization	2	4.01	3.21e-04	1.23e-03	21|193|171|3527	PF00019;PF00025;PF00076;PF00130;PF00134;PF00169;PF00179;PF00241;PF00400;PF00583;PF00611;PF00688;PF01064;PF01585;PF02181;PF03165;PF06325;PF06367;PF06371;PF07679;PF07719
Group	GO:0032844	regulation of homeostatic process	2	4.34	3.29e-04	1.25e-03	12|193|70|3527	PF00019;PF00057;PF00179;PF00254;PF00388;PF00452;PF00622;PF00688;PF00969;PF03226;PF12796;PF13716
Group	GO:0001568	blood vessel development	2	4.12	3.90e-04	1.46e-03	15|193|103|3527	PF00019;PF00093;PF00169;PF00341;PF00618;PF00640;PF00688;PF01064;PF01403;PF01437;PF01833;PF07645;PF07679;PF12796;PF13716
Group	GO:0072507	divalent inorganic cation homeostasis	2	4.22	4.32e-04	1.60e-03	12|193|72|3527	PF00122;PF00130;PF00254;PF00388;PF00452;PF00622;PF00689;PF00690;PF00702;PF01699;PF02177;PF12924
Group	GO:0007219	Notch signaling pathway	2	4.54	4.55e-04	1.68e-03	8|193|35|3527	PF00400;PF01370;PF01417;PF01833;PF01843;PF02825;PF07645;PF12796
Group	GO:0001701	in utero embryonic development	2	4.32	4.71e-04	1.71e-03	10|193|53|3527	PF00169;PF00341;PF00640;PF00757;PF00989;PF01030;PF01064;PF01417;PF03165;PF07679
Group	GO:0050776	regulation of immune response	2	4.01	4.68e-04	1.71e-03	16|193|116|3527	PF00057;PF00130;PF00169;PF00179;PF00240;PF00388;PF00611;PF00651;PF00969;PF01476;PF04055;PF07534;PF07645;PF07679;PF08246;PF13855
Group	GO:0072347	response to anesthetic	2	5.54	5.12e-04	1.75e-03	4|193|8|3527	PF00052;PF00053;PF00057;PF07679
Group	GO:0045199	maintenance of epithelial cell apical/basal polarity	2	5.54	5.12e-04	1.75e-03	4|193|8|3527	PF00052;PF00053;PF00057;PF07679
Group	GO:0008213	protein alkylation	2	4.40	4.86e-04	1.75e-03	9|193|44|3527	PF00076;PF00134;PF00400;PF00622;PF01753;PF05033;PF06325;PF07719;PF12796
Group	GO:0040017	positive regulation of locomotion	2	4.25	5.51e-04	1.87e-03	10|193|54|3527	PF00019;PF00053;PF00055;PF00093;PF00130;PF00169;PF00341;PF00688;PF07679;PF08246
Group	GO:0045596	negative regulation of cell differentiation	2	3.93	5.69e-04	1.93e-03	16|193|118|3527	PF00019;PF00098;PF00514;PF00688;PF00778;PF00780;PF01064;PF01403;PF01417;PF02177;PF03165;PF07645;PF07679;PF12796;PF12924;PF13716
Group	GO:0006898	receptor-mediated endocytosis	2	4.56	5.83e-04	1.95e-03	7|193|28|3527	PF00040;PF00057;PF00169;PF00350;PF00397;PF00611;PF07645
Group	GO:0048511	rhythmic process	2	4.18	6.42e-04	2.06e-03	10|193|55|3527	PF00019;PF00027;PF00076;PF00098;PF00452;PF00583;PF00688;PF00989;PF07679;PF13716
Group	GO:0032970	regulation of actin filament-based process	2	4.18	6.42e-04	2.06e-03	10|193|55|3527	PF00130;PF00169;PF00241;PF00400;PF00610;PF00611;PF00786;PF02181;PF07653;PF12796
Group	GO:0050678	regulation of epithelial cell proliferation	2	4.18	6.42e-04	2.06e-03	10|193|55|3527	PF00019;PF00130;PF00341;PF00514;PF00688;PF00757;PF01030;PF01064;PF03165;PF07679
Group	GO:0009725	response to hormone stimulus	2	3.82	6.48e-04	2.07e-03	18|193|143|3527	PF00019;PF00045;PF00130;PF00169;PF00388;PF00413;PF00452;PF00514;PF00640;PF00688;PF00757;PF01030;PF01064;PF02218;PF07525;PF07653;PF10409;PF13855
Group	GO:0080135	regulation of cellular response to stress	2	3.98	6.65e-04	2.11e-03	13|193|86|3527	PF00040;PF00169;PF00179;PF00397;PF00452;PF00640;PF00778;PF00780;PF00786;PF01753;PF01843;PF07653;PF13855
Group	GO:0045926	negative regulation of growth	2	4.23	6.87e-04	2.17e-03	9|193|46|3527	PF00019;PF00226;PF00611;PF00622;PF00640;PF00643;PF00688;PF01403;PF10409
Group	GO:0051046	regulation of secretion	2	3.89	7.45e-04	2.33e-03	14|193|98|3527	PF00019;PF00027;PF00040;PF00169;PF00610;PF00618;PF00622;PF00688;PF00969;PF01064;PF01833;PF02214;PF04055;PF04144
Group	GO:0043069	negative regulation of programmed cell death	2	3.82	7.98e-04	2.48e-03	15|193|110|3527	PF00019;PF00130;PF00169;PF00341;PF00452;PF00594;PF00688;PF00757;PF01030;PF07653;PF08246;PF10277;PF12763;PF13855;PF13920
Group	GO:0009416	response to light stimulus	2	3.78	8.28e-04	2.56e-03	16|193|122|3527	PF00057;PF00076;PF00098;PF00122;PF00134;PF00226;PF00400;PF00452;PF00689;PF00690;PF00702;PF00989;PF02177;PF12924;PF13716;PF13855
Group	GO:0030111	regulation of Wnt receptor signaling pathway	2	4.04	8.61e-04	2.62e-03	10|193|57|3527	PF00019;PF00057;PF00400;PF00514;PF00612;PF00688;PF00778;PF02825;PF07679;PF12796
Group	GO:0001738	morphogenesis of a polarized epithelium	2	4.32	9.14e-04	2.68e-03	7|193|30|3527	PF00053;PF00130;PF00514;PF00612;PF00651;PF01843;PF06297
Group	GO:0030003	cellular cation homeostasis	2	3.75	9.67e-04	2.82e-03	15|193|112|3527	PF00122;PF00130;PF00254;PF00388;PF00400;PF00452;PF00622;PF00689;PF00690;PF00702;PF01496;PF01699;PF02177;PF02225;PF12924
Group	GO:0006357	regulation of transcription from RNA polymerase II promoter	2	3.61	9.86e-04	2.86e-03	20|193|173|3527	PF00019;PF00400;PF00435;PF00514;PF00651;PF00688;PF00989;PF01833;PF02177;PF02201;PF03165;PF04762;PF07645;PF07679;PF08711;PF12796;PF12924;PF13716;PF13854;PF13920
Group	GO:0033365	protein localization to organelle	2	3.71	1.06e-03	3.07e-03	15|193|113|3527	PF00019;PF00025;PF00226;PF00240;PF00350;PF00397;PF00435;PF00514;PF00688;PF02145;PF03810;PF04695;PF07645;PF08389;PF12796
Group	GO:0030855	epithelial cell differentiation	2	3.86	1.10e-03	3.17e-03	11|193|69|3527	PF00019;PF00024;PF00130;PF00514;PF00612;PF00640;PF00688;PF01064;PF03165;PF07645;PF07679
Group	GO:0016337	cell-cell adhesion	2	4.00	1.11e-03	3.18e-03	9|193|49|3527	PF00122;PF00169;PF00514;PF00688;PF00689;PF00690;PF00702;PF07679;PF13855
Group	GO:0008038	neuron recognition	2	4.36	1.15e-03	3.27e-03	6|193|23|3527	PF00435;PF00651;PF01437;PF02177;PF07679;PF12924
Group	GO:0045165	cell fate commitment	2	3.68	1.23e-03	3.48e-03	14|193|103|3527	PF00019;PF00076;PF00130;PF00435;PF00651;PF00688;PF00989;PF01064;PF01465;PF03165;PF07645;PF07653;PF07679;PF10409
Group	GO:0048732	gland development	2	3.74	1.29e-03	3.59e-03	12|193|81|3527	PF00122;PF00341;PF00514;PF00702;PF00757;PF00989;PF01030;PF01403;PF01553;PF07679;PF10409;PF13716
Group	GO:0001817	regulation of cytokine production	2	3.69	1.44e-03	3.92e-03	12|193|82|3527	PF00019;PF00076;PF00130;PF00240;PF00622;PF00651;PF00688;PF00969;PF04055;PF04144;PF12796;PF13855
Group	GO:0045927	positive regulation of growth	2	3.78	1.49e-03	3.98e-03	10|193|61|3527	PF00133;PF00169;PF00612;PF00757;PF00989;PF01030;PF01064;PF03165;PF12796;PF13716
Group	GO:0010942	positive regulation of cell death	2	3.55	1.52e-03	4.06e-03	15|193|117|3527	PF00019;PF00169;PF00240;PF00397;PF00452;PF00514;PF00643;PF00688;PF01335;PF01585;PF07653;PF07679;PF08246;PF10409;PF13716
Group	GO:0030001	metal ion transport	2	3.49	1.66e-03	4.39e-03	16|193|130|3527	PF00027;PF00122;PF00153;PF00254;PF00388;PF00622;PF00651;PF00689;PF00690;PF00702;PF01699;PF01833;PF02214;PF02225;PF07707;PF12796
Group	GO:0002684	positive regulation of immune system process	2	3.52	1.66e-03	4.40e-03	15|193|118|3527	PF00057;PF00130;PF00169;PF00179;PF00240;PF00388;PF00611;PF00651;PF00969;PF01476;PF04055;PF05790;PF07534;PF07645;PF13855
Group	GO:0043244	regulation of protein complex disassembly	2	4.09	1.83e-03	4.75e-03	6|193|25|3527	PF00241;PF00435;PF00514;PF00622;PF00643;PF12348
Group	GO:0060348	bone development	2	3.81	1.92e-03	4.91e-03	8|193|43|3527	PF00019;PF00052;PF00053;PF00057;PF00622;PF00688;PF07645;PF07679
Group	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	2	3.81	1.92e-03	4.91e-03	8|193|43|3527	PF00019;PF00093;PF00683;PF00688;PF01064;PF03165;PF07645;PF12796
Group	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	2	3.81	1.92e-03	4.91e-03	8|193|43|3527	PF00019;PF00341;PF00397;PF00683;PF00688;PF01064;PF03165;PF07645
Group	GO:0017038	protein import	2	3.66	1.91e-03	4.91e-03	10|193|63|3527	PF00019;PF00226;PF00400;PF00514;PF00688;PF02145;PF03810;PF04695;PF07645;PF12796
Group	GO:0051052	regulation of DNA metabolic process	2	3.59	1.98e-03	5.04e-03	11|193|74|3527	PF00019;PF00134;PF00179;PF00341;PF00651;PF00688;PF01336;PF07679;PF12171;PF12756;PF12895
Group	GO:0034220	ion transmembrane transport	2	3.60	2.16e-03	5.37e-03	10|193|64|3527	PF00027;PF00122;PF00153;PF00452;PF00622;PF00690;PF00702;PF01699;PF02214;PF12796
Group	GO:0007548	sex differentiation	2	3.54	2.22e-03	5.48e-03	11|193|75|3527	PF00019;PF00076;PF00098;PF00134;PF00400;PF00452;PF00651;PF00688;PF00989;PF01064;PF07679
Group	GO:0006836	neurotransmitter transport	2	3.73	2.24e-03	5.51e-03	8|193|44|3527	PF00122;PF00130;PF00169;PF00640;PF00690;PF01217;PF01417;PF12763
Group	GO:0045893	positive regulation of transcription, DNA-dependent	2	3.29	2.55e-03	6.23e-03	17|193|148|3527	PF00019;PF00400;PF00435;PF00514;PF00688;PF00757;PF00989;PF01030;PF01833;PF02177;PF03165;PF07645;PF08210;PF09816;PF12796;PF12924;PF13716
Group	GO:0070482	response to oxygen levels	2	3.58	2.59e-03	6.30e-03	9|193|55|3527	PF00019;PF00045;PF00341;PF00413;PF00643;PF00688;PF00989;PF02145;PF13716
Group	GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	2	3.65	2.60e-03	6.32e-03	8|193|45|3527	PF00122;PF00179;PF00240;PF00689;PF00690;PF00702;PF12796;PF13920
Group	GO:0019216	regulation of lipid metabolic process	2	3.43	3.07e-03	7.26e-03	10|193|67|3527	PF00019;PF00098;PF00169;PF00341;PF00400;PF00688;PF07653;PF07679;PF07719;PF12697
Group	GO:0060485	mesenchyme development	2	3.45	3.33e-03	7.84e-03	9|193|57|3527	PF00019;PF00688;PF00757;PF01030;PF01064;PF01403;PF01833;PF07645;PF07679
Group	GO:0048705	skeletal system morphogenesis	2	3.50	3.46e-03	8.09e-03	8|193|47|3527	PF00019;PF00052;PF00053;PF00057;PF00688;PF03165;PF07645;PF07679
Group	GO:0048285	organelle fission	2	3.33	3.82e-03	8.88e-03	10|193|69|3527	PF00134;PF00350;PF00400;PF00452;PF00780;PF02148;PF05033;PF12348;PF12895;PF13920
Group	GO:0072511	divalent inorganic cation transport	2	3.33	3.82e-03	8.88e-03	10|193|69|3527	PF00122;PF00254;PF00388;PF00622;PF00689;PF00690;PF00702;PF01699;PF01833;PF12796
Group	GO:0055065	metal ion homeostasis	2	3.24	3.88e-03	8.99e-03	12|193|92|3527	PF00122;PF00130;PF00254;PF00388;PF00452;PF00622;PF00689;PF00690;PF00702;PF02177;PF02225;PF12924
Group	GO:0016055	Wnt receptor signaling pathway	2	3.53	3.90e-03	9.01e-03	7|193|38|3527	PF00057;PF00435;PF00514;PF00610;PF00778;PF02377;PF07707
Group	GO:0045765	regulation of angiogenesis	2	3.43	3.96e-03	9.10e-03	8|193|48|3527	PF00093;PF00130;PF00169;PF00341;PF00643;PF07645;PF08246;PF13716
Group	GO:0051325	interphase	2	3.27	4.25e-03	9.54e-03	10|193|70|3527	PF00019;PF00134;PF00452;PF00581;PF00688;PF01336;PF01833;PF02177;PF12924;PF14324
Group	GO:0045822	negative regulation of heart contraction	3	8.39	2.68e-06	1.80e-05	5|193|6|3527	PF00122;PF00169;PF00689;PF00690;PF00702
Group	GO:0051897	positive regulation of protein kinase B signaling cascade	3	7.34	3.26e-06	2.15e-05	7|193|14|3527	PF00019;PF00594;PF00688;PF00757;PF01030;PF07653;PF12763
Group	GO:0007601	visual perception	3	6.39	7.25e-06	4.38e-05	9|193|27|3527	PF00027;PF00053;PF00055;PF00350;PF00415;PF00612;PF03607;PF07719;PF13385
Group	GO:0032468	Golgi calcium ion homeostasis	3	8.32	8.70e-06	5.03e-05	4|193|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0032472	Golgi calcium ion transport	3	8.32	8.70e-06	5.03e-05	4|193|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0048840	otolith development	3	8.32	8.70e-06	5.03e-05	4|193|4|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0002026	regulation of the force of heart contraction	3	7.17	9.13e-06	5.18e-05	6|193|11|3527	PF00122;PF00169;PF00689;PF00690;PF00702;PF01699
Group	GO:0002028	regulation of sodium ion transport	3	6.75	9.90e-06	5.53e-05	7|193|16|3527	PF00122;PF00169;PF00397;PF00435;PF00689;PF00690;PF00702
Group	GO:0050920	regulation of chemotaxis	3	6.49	1.61e-05	8.59e-05	7|193|17|3527	PF00019;PF00341;PF00688;PF01403;PF01437;PF01833;PF07653
Group	GO:0033135	regulation of peptidyl-serine phosphorylation	3	7.10	2.28e-05	1.17e-04	5|193|8|3527	PF00019;PF00169;PF00452;PF00688;PF00786
Group	GO:0008542	visual learning	3	6.46	3.09e-05	1.55e-04	6|193|13|3527	PF00122;PF00689;PF00690;PF00702;PF02177;PF12924
Group	GO:0055071	manganese ion homeostasis	3	7.33	4.17e-05	2.01e-04	4|193|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0051238	sequestering of metal ion	3	7.33	4.17e-05	2.01e-04	4|193|5|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0051017	actin filament bundle assembly	3	5.69	4.63e-05	2.22e-04	8|193|26|3527	PF00611;PF00612;PF02181;PF02214;PF06367;PF06371;PF07653;PF12796
Group	GO:0008358	maternal determination of anterior/posterior axis, embryo	3	6.16	5.16e-05	2.46e-04	6|193|14|3527	PF00076;PF00622;PF00651;PF01064;PF07525;PF13091
Group	GO:0045667	regulation of osteoblast differentiation	3	5.82	5.56e-05	2.63e-04	7|193|20|3527	PF00019;PF00093;PF00514;PF00688;PF01064;PF03165;PF07645
Group	GO:0006275	regulation of DNA replication	3	5.40	8.38e-05	3.75e-04	8|193|28|3527	PF00019;PF00134;PF00341;PF00688;PF01336;PF12171;PF12756;PF12895
Group	GO:0060491	regulation of cell projection assembly	3	5.45	1.11e-04	4.94e-04	7|193|22|3527	PF00130;PF00612;PF00786;PF02181;PF06367;PF06371;PF12796
Group	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	3	5.64	1.25e-04	5.43e-04	6|193|16|3527	PF00019;PF00169;PF00341;PF00688;PF07653;PF07679
Group	GO:0007173	epidermal growth factor receptor signaling pathway	3	5.28	1.53e-04	6.52e-04	7|193|23|3527	PF00019;PF00130;PF00169;PF00688;PF00757;PF01030;PF07645
Group	GO:0048640	negative regulation of developmental growth	3	5.84	1.64e-04	6.97e-04	5|193|11|3527	PF00019;PF00611;PF00622;PF00688;PF01403
Group	GO:0007309	oocyte axis specification	3	5.42	1.85e-04	7.75e-04	6|193|17|3527	PF00076;PF00130;PF00622;PF00651;PF07525;PF13091
Group	GO:0017145	stem cell division	3	5.12	2.06e-04	8.55e-04	7|193|24|3527	PF00019;PF00076;PF00130;PF00640;PF00688;PF01064;PF03165
Group	GO:0010770	positive regulation of cell morphogenesis involved in differentiation	3	6.02	2.67e-04	1.04e-03	4|193|7|3527	PF00019;PF00514;PF00688;PF03165
Group	GO:0006828	manganese ion transport	3	6.02	2.67e-04	1.04e-03	4|193|7|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0007254	JNK cascade	3	5.21	2.65e-04	1.04e-03	6|193|18|3527	PF00240;PF00640;PF00780;PF00786;PF01843;PF07653
Group	GO:0007050	cell cycle arrest	3	5.02	3.70e-04	1.40e-03	6|193|19|3527	PF00019;PF00350;PF00397;PF00640;PF00688;PF07645
Group	GO:0035265	organ growth	3	5.24	4.18e-04	1.56e-03	5|193|13|3527	PF00019;PF00688;PF07679;PF12796;PF14324
Group	GO:0010717	regulation of epithelial to mesenchymal transition	3	5.54	5.12e-04	1.75e-03	4|193|8|3527	PF00019;PF00514;PF00688;PF03165
Group	GO:0000186	activation of MAPKK activity	3	5.54	5.12e-04	1.75e-03	4|193|8|3527	PF00019;PF00688;PF00780;PF07653
Group	GO:0050772	positive regulation of axonogenesis	3	5.54	5.12e-04	1.75e-03	4|193|8|3527	PF01403;PF01437;PF07679;PF13855
Group	GO:0010594	regulation of endothelial cell migration	3	5.54	5.12e-04	1.75e-03	4|193|8|3527	PF00019;PF00130;PF00341;PF00688
Group	GO:0060972	left/right pattern formation	3	5.54	5.12e-04	1.75e-03	4|193|8|3527	PF00400;PF00612;PF05033;PF12796
Group	GO:0050918	positive chemotaxis	3	5.54	5.12e-04	1.75e-03	4|193|8|3527	PF00019;PF00341;PF00688;PF02145
Group	GO:0009624	response to nematode	3	5.54	5.12e-04	1.75e-03	4|193|8|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0006885	regulation of pH	3	4.84	5.05e-04	1.75e-03	6|193|20|3527	PF00122;PF00400;PF00689;PF00690;PF00702;PF01496
Group	GO:0001666	response to hypoxia	3	4.31	5.80e-04	1.95e-03	9|193|45|3527	PF00019;PF00045;PF00341;PF00413;PF00643;PF00688;PF00989;PF02145;PF13716
Group	GO:0007266	Rho protein signal transduction	3	4.98	6.22e-04	2.02e-03	5|193|14|3527	PF00169;PF00435;PF00612;PF00651;PF02185
Group	GO:0045834	positive regulation of lipid metabolic process	3	4.44	7.34e-04	2.30e-03	7|193|29|3527	PF00019;PF00169;PF00341;PF00688;PF07653;PF07679;PF12697
Group	GO:0009648	photoperiodism	3	5.15	8.81e-04	2.62e-03	4|193|9|3527	PF00076;PF00098;PF00400;PF00989
Group	GO:0045186	zonula adherens assembly	3	5.15	8.81e-04	2.62e-03	4|193|9|3527	PF00130;PF00169;PF00435;PF07653
Group	GO:0007176	regulation of epidermal growth factor-activated receptor activity	3	5.15	8.81e-04	2.62e-03	4|193|9|3527	PF01585;PF02177;PF07525;PF12924
Group	GO:0002040	sprouting angiogenesis	3	5.15	8.81e-04	2.62e-03	4|193|9|3527	PF00019;PF00341;PF00688;PF12796
Group	GO:0048009	insulin-like growth factor receptor signaling pathway	3	5.15	8.81e-04	2.62e-03	4|193|9|3527	PF00169;PF00757;PF01030;PF02145
Group	GO:0006611	protein export from nucleus	3	5.15	8.81e-04	2.62e-03	4|193|9|3527	PF00019;PF00688;PF03810;PF08389
Group	GO:0060571	morphogenesis of an epithelial fold	3	5.15	8.81e-04	2.62e-03	4|193|9|3527	PF00130;PF00757;PF01030;PF07679
Group	GO:0016339	calcium-dependent cell-cell adhesion	3	5.15	8.81e-04	2.62e-03	4|193|9|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0043112	receptor metabolic process	3	4.75	8.92e-04	2.62e-03	5|193|15|3527	PF00019;PF00082;PF00169;PF00397;PF00688
Group	GO:0001892	embryonic placenta development	3	4.51	8.87e-04	2.62e-03	6|193|22|3527	PF00169;PF00341;PF00757;PF00989;PF01030;PF07679
Group	GO:0042462	eye photoreceptor cell development	3	4.54	1.24e-03	3.48e-03	5|193|16|3527	PF00415;PF00612;PF00651;PF03607;PF10409
Group	GO:0070167	regulation of biomineral tissue development	3	4.54	1.24e-03	3.48e-03	5|193|16|3527	PF00019;PF00594;PF00688;PF01064;PF07645
Group	GO:0010464	regulation of mesenchymal cell proliferation	3	4.54	1.24e-03	3.48e-03	5|193|16|3527	PF00019;PF00341;PF00688;PF03165;PF07679
Group	GO:0042036	negative regulation of cytokine biosynthetic process	3	4.81	1.41e-03	3.86e-03	4|193|10|3527	PF00019;PF00076;PF00688;PF12796
Group	GO:0045778	positive regulation of ossification	3	4.81	1.41e-03	3.86e-03	4|193|10|3527	PF00019;PF00688;PF01064;PF07645
Group	GO:0051784	negative regulation of nuclear division	3	4.81	1.41e-03	3.86e-03	4|193|10|3527	PF00019;PF00688;PF02148;PF07679
Group	GO:0060026	convergent extension	3	4.81	1.41e-03	3.86e-03	4|193|10|3527	PF00610;PF00778;PF02377;PF06297
Group	GO:0050796	regulation of insulin secretion	3	4.22	1.46e-03	3.95e-03	6|193|24|3527	PF00019;PF00027;PF00688;PF00969;PF01064;PF02214
Group	GO:0007088	regulation of mitosis	3	4.22	1.46e-03	3.95e-03	6|193|24|3527	PF00019;PF00341;PF00688;PF02148;PF07679;PF12895
Group	GO:0060363	cranial suture morphogenesis	3	5.36	1.49e-03	3.98e-03	3|193|5|3527	PF00019;PF00688;PF07679
Group	GO:0006818	hydrogen transport	3	4.35	1.68e-03	4.41e-03	5|193|17|3527	PF00122;PF00153;PF00690;PF00702;PF01496
Group	GO:0045732	positive regulation of protein catabolic process	3	4.35	1.68e-03	4.41e-03	5|193|17|3527	PF00397;PF00400;PF00514;PF00778;PF07525
Group	GO:0051048	negative regulation of secretion	3	4.09	1.83e-03	4.75e-03	6|193|25|3527	PF00019;PF00622;PF00688;PF01064;PF01833;PF04055
Group	GO:0006984	ER-nucleus signaling pathway	3	4.09	1.83e-03	4.75e-03	6|193|25|3527	PF00122;PF00226;PF00400;PF00689;PF00690;PF00702
Group	GO:0009950	dorsal/ventral axis specification	3	4.51	2.12e-03	5.27e-03	4|193|11|3527	PF00057;PF00076;PF00778;PF03165
Group	GO:0048730	epidermis morphogenesis	3	4.51	2.12e-03	5.27e-03	4|193|11|3527	PF00019;PF00688;PF01843;PF07679
Group	GO:0090114	COPII-coated vesicle budding	3	4.51	2.12e-03	5.27e-03	4|193|11|3527	PF00400;PF00651;PF04810;PF07707
Group	GO:0032321	positive regulation of Rho GTPase activity	3	4.51	2.12e-03	5.27e-03	4|193|11|3527	PF00611;PF00612;PF06920;PF14429
Group	GO:0001938	positive regulation of endothelial cell proliferation	3	4.51	2.12e-03	5.27e-03	4|193|11|3527	PF00019;PF00130;PF00341;PF00688
Group	GO:0022405	hair cycle process	3	4.17	2.22e-03	5.48e-03	5|193|18|3527	PF00019;PF00688;PF00757;PF01030;PF07679
Group	GO:0061099	negative regulation of protein tyrosine kinase activity	3	4.80	2.85e-03	6.88e-03	3|193|6|3527	PF00400;PF01585;PF07525
Group	GO:0043555	regulation of translation in response to stress	3	4.80	2.85e-03	6.88e-03	3|193|6|3527	PF00076;PF00098;PF05773
Group	GO:0061136	regulation of proteasomal protein catabolic process	3	4.01	2.89e-03	6.90e-03	5|193|19|3527	PF00240;PF00400;PF00778;PF00789;PF02148
Group	GO:0001649	osteoblast differentiation	3	4.01	2.89e-03	6.90e-03	5|193|19|3527	PF00019;PF00093;PF00688;PF03165;PF13716
Group	GO:0019722	calcium-mediated signaling	3	4.25	3.04e-03	7.22e-03	4|193|12|3527	PF00122;PF00689;PF00690;PF00702
Group	GO:0072012	glomerulus vasculature development	3	4.25	3.04e-03	7.22e-03	4|193|12|3527	PF00019;PF00341;PF00688;PF07679
Group	GO:0007093	mitotic cell cycle checkpoint	3	3.73	3.40e-03	7.99e-03	6|193|28|3527	PF00019;PF00134;PF00452;PF00688;PF12796;PF14324
Group	GO:0007623	circadian rhythm	3	3.62	4.10e-03	9.38e-03	6|193|29|3527	PF00027;PF00076;PF00098;PF00583;PF00989;PF13716
Group	GO:0006901	vesicle coating	3	4.02	4.21e-03	9.47e-03	4|193|13|3527	PF00611;PF00651;PF01217;PF07707
Group	GO:0050885	neuromuscular process controlling balance	3	4.02	4.21e-03	9.47e-03	4|193|13|3527	PF02177;PF07653;PF12796;PF12924
Group	GO:0007179	transforming growth factor beta receptor signaling pathway	3	4.02	4.21e-03	9.47e-03	4|193|13|3527	PF00341;PF00683;PF01064;PF07645
Group	GO:0042177	negative regulation of protein catabolic process	3	4.02	4.21e-03	9.47e-03	4|193|13|3527	PF00240;PF00789;PF01335;PF02148
Group	GO:0051322	anaphase	3	4.02	4.21e-03	9.47e-03	4|193|13|3527	PF00651;PF02148;PF07707;PF13964
Group	GO:0033138	positive regulation of peptidyl-serine phosphorylation	4	6.12	6.20e-04	2.02e-03	3|193|4|3527	PF00019;PF00688;PF00786
Group	GO:0008053	mitochondrial fusion	4	6.12	6.20e-04	2.02e-03	3|193|4|3527	PF00350;PF00452;PF13091
Group	GO:0018095	protein polyglutamylation	4	6.12	6.20e-04	2.02e-03	3|193|4|3527	PF00581;PF03133;PF07719
Group	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	4	6.12	6.20e-04	2.02e-03	3|193|4|3527	PF00019;PF00688;PF01064
Group	GO:0007183	SMAD protein complex assembly	4	6.12	6.20e-04	2.02e-03	3|193|4|3527	PF00019;PF00688;PF03165
Group	GO:0045648	positive regulation of erythrocyte differentiation	4	5.36	1.49e-03	3.98e-03	3|193|5|3527	PF00019;PF00688;PF12796
